HSCS (HeartSciences Inc. Common Stock) Stock Analysis - AI Report

HeartSciences Inc. Common Stock (HSCS) is a publicly traded Healthcare sector company. As of May 21, 2026, HSCS trades at $1.99 with a market cap of $5.92M and a P/E ratio of -0.40. HSCS moved +0.00% today. Year to date, HSCS is -37.34%; over the trailing twelve months it is -57.02%. Its 52-week range spans $1.77 to $6.47. Analyst consensus is buy with an average price target of $10.00. Rallies surfaces HSCS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on HSCS?

Rallies AI research for HSCS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

HSCS Key Metrics

Key financial metrics for HSCS
MetricValue
Price$1.99
Market Cap$5.92M
P/E Ratio-0.40
EPS$-4.61
Dividend Yield0.00%
52-Week High$6.47
52-Week Low$1.77
Volume145
Avg Volume0
Revenue (TTM)$8.67K
Net Income$-8.49M
Gross Margin57.92%

Latest HSCS News

Recent HSCS Insider Trades

  • HILZ MARK T sold 4.42K (~$15.62K) on Jul 29, 2025.

HSCS Analyst Consensus

2 analysts cover HSCS: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.00.

Common questions about HSCS

What is the AI research view on HSCS?
Rallies AI research for HSCS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for HSCS?
Rallies AI research for HSCS combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is HSCS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for HSCS. It does not provide personalized investment advice.
HSCS

HSCS